Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,778.00
Bid: 1,774.00
Ask: 1,774.50
Change: -10.50 (-0.59%)
Spread: 0.50 (0.028%)
Open: 1,796.00
High: 1,808.50
Low: 1,772.50
Prev. Close: 1,788.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK MIDDAY BRIEFING: Unilever Kicks Off New Earnings Season

Tue, 21st Jan 2014 12:59

LONDON (Alliance News) - Anglo-Dutch consumer goods and food giant Unilever Tuesday kicked off the latest UK earnings season, reporting lower revenues for the fourth quarter and whole of 2013, but its earnings beat expectations as margins were supported by price increases and cost cutting.

The company said it is facing increased competition in its still-weak developed markets, while growth has moderated in emerging markets, a reality that Chief Executive Paul Polman says the company now has to just "deal with". While its personal care brands, like Dove, are doing well, sales of its refreshment brands and some of its food brands, like its spreads, fell.

Warning that competition will remain fierce in 2014, Polman pledged to stay focused on raising margins, even though it will invest in re-invigorating its stalled food business.

Unilever was joined by the likes of SABMiller, PZ Cussons and digital media company Next Fifteen Communications Group in warning that recent currency moves were weighing on earnings.

Brewing giant SABMiller reported higher sales for its fiscal third quarter that met analysts' expectations, as volumes rose and it managed to raise prices. Growth continued to be driven by emerging markets like Africa, Latin America and China. However, "depreciation of key currencies against the US dollar will adversely impact reported results," it warned.

Unilever's 2013 operating profit came in at EUR7.51 billion, up 8% from EUR7.0 billion in 2012. However, it said the increase would have been 15% is currencies had stayed constant during the year.

Next Fifteen, meanwhile, said the current strength of sterling against both the US dollar and the Euro will hold back its revenues and profits, even though trading was off to a strong start in the financial year.

In economic news, British Chancellor of the Exchequer George Osborne will be eagerly awaiting the latest growth forecasts from the International Monetary Fund later Tuesday. The fund is widely reported to be about to raise its forecasts for UK growth more than for any other major economy.

The United Nations Tuesday predicted that the world economy will grow 3% this year and 3.3% in 2015, after growth of 2.1% in 2012.

Backing the growth forecasts, the International Energy Agency nudged up its global oil demand growth forecast for 2014, citing demand strength. It moved up its global oil demand forecast by 1.3 million barrels a day, after reporting stronger-than-expected demand in the fourth quarter of last year.

In the UK, the value of mortgages disbursed by UK banks remained broadly stable in December from the previous month, figures released by the Council for Mortgage Lenders revealed. The total value of mortgage lending was GBP17 billion in December, up 49% on the same month in 2012 and the highest for that month since December 2007.

Meanwhile, British manufacturing order growth during three months to January hit the highest since April 2011, survey data from the Confederation of British Industry showed Tuesday.

Elsewhere, The Thai government has declared a 60-day state of emergency in Bangkok and parts of nearby province, after almost 80 days of anti-government protests in the capital that have taken a more violent turn in recent days, media reports in the country say.

Protests in Ukraine capital Kiev also continued overnight, when hundreds of radical opposition supporters pelted police with Molotov cocktails and cobblestones. Opposition leader and former boxing champion Vitaly Klitschko warned protesters that the government was sending paid thugs to destabilise the situation.

Iran may be taking steps to limit its nuclear programme, but that doesn't mean it's in step with the majority of the international community on regional issues. UN Secretary General Ban Ki-moon has revoked his invitation for Tehran to attend Wednesday's Syrian peace conference, saying Iranian officials had failed to support the goals of the international talks.

--------

FTSE 100: Down 0.04% at 6,826.99
FTSE 250: Up 0.2% at 16,220.25
AIM ALL-SHARE: Down 0.2% at 882.51
GBP-USD: 1.6444
EUR-USD: 1.3555
GOLD: USD1,254.86 an ounce
OIL (Brent): USD106.26 a barrel

--------

KEY UK CORPORATE NEWS:

FTSE 100: IMI is proposing to return GBP620 million, or 200 pence a share, to shareholders from proceeds of the disposal of its Beverage Dispense and Merchandising division. Melrose Industries, meanwhile, said it plans to use part of the proceeds from FKI business disposals to return about GBP600 million to shareholders, after using some of the proceeds to pay down borrowings. GlaxoSmithKline's joint venture Viiv Healthcare Ltd has had its Tivicay integrase inhibitor approved for use in combination with other anti-retroviral medicinal products for the treatment of HIV by the European Commission.

FTSE 250: African Barrick Gold has exceeded its initial 2013 gold production guidance and continued its cost cutting. Gold production of 641,931 ounces was 3% higher than in 2012 and significantly exceeded guidance of between 540,000 and 600,000 ounces. Its preliminary fourth quarter all-in sustaining cost was USD1,171 per ounce of gold sold, down 30% on the previous year and 8% on the previous quarter. Polymetal International produced 1.3 million ounces of gold equivalent in 2013, a 21% increase on the previous year and above its production guidance of 1.2 million ounces. Cairn Energy plans to drill nine wells in its 2014 exploration programme across a mix of different areas. John Wood Group has secured two major contract extensions in Africa worth USD250 million. Carphone Warehouse has reiterated its full-year guidance after it saw 3.1% like-for-like revenue growth in its fiscal third quarter and encouraging progress on its sales of 4G services. Like-for-like sales were up 5% in the UK. Marston's says trading in the financial year to date has been "encouraging", with profitability in line with expectations, boosted by good trading over the Christmas and New Year period. The brewer also said that it achieved like-for-like sales growth across is business estate. PZ Cussons said revenue for the half-year was up 4.1%, in line with management expectations, as it boosted its interim dividend to 2.53 pence per share. Restaurant Group has started searching for a replacement for Chief Executive Officer Andrew Page, who will retire in August. Intermediate Capital Group said it raised EUR1.1 billion of new third-party money in the third quarter, lifting nine-month gross inflows above the full previous year. Petra Diamonds has found an "exceptional" 29.6 carat blue diamond at its Cullinan mine in South Africa.

AIM: Rose Petroleum is a big gainer after it completed the previously announced acquisition of two fracking licences in Germany. The company said it has purchased the entire share capital of Parkyn Energy Holdings PLC, which owns 100% of the German licences through its subsidiary Parkyn Energy Germany Ltd, for EUR400,000. Pressure Technologies is doing well after its alternative energy division, Chesterfield BioGas, was awarded a GBP4.2 million contract to upgrade biogas supply equipment to the UK energy grid, and is also in advanced talks on potential further deals. IQE is another gainer as it said it expects to report 2013 revenue of at least GBP126.0 million, up 43% from GBP88.0 million in 2012. The company also expects Ebitda of at least GBP24.5 million, up 49% from GBP16.4 million in 2012, as it improved its operational efficiency. Touchstone Gold is a big faller after it warned that if it cannot find additional funding it will not be able to meet scheduled payments to vendors of its concession contracts. Touchstone also said it has managed to enter into an agreement to grant 6.5 million shares at a price of 0.932 pence per share by way of a private placement. Red Rock Resources is another faller after it raised GBP360,000 by placing 77 million shares at 0.47 pence each. The proceeds of the placing will be put towards repayments and working capital. Corero Network Security is down after the network security provider said it expects its Ebitda loss to widen for 2013.

--------

AFTERNOON WATCHLIST: US Redbook Index, IMF Global Growth Forecasts

--------

Wednesday's Key UK Corporate Events

JD Wetherspoon Trading statement
Optos Interim Management Statement
BHP Billiton December Quarter Production, Exploration, Development Report
Hochschild Mining Production Report
Land Securities Group Interim Management Statement
Noble Corporation Q4 Results
Sage Group Interim Management Statement
London Mining Production Report
Findel Interim Management Statement

-------

Wednesday's Key Economic Events

All Day World Economic Forum - Davos
03:00 Japan BoJ Interest Rate Decision
09:30 UK Bank of England Minutes
09:30 UK ILO Unemployment Rate
09:30 UK Public Sector Net Borrowing
12:00 US MBA Mortgage Applications

-------

By Steve McGrath; steve.mcgrath@alliancenews.com; @stevemcgrath1

Copyright © 2014 Alliance News Limited. All Rights Reserved.

More News
7 Mar 2024 09:38

GSK observes positive data in Blenrep trial for blood cancer treatment

(Alliance News) - GSK PLC on Thursday announced positive results for Blenrep for the treatment of multiple myeloma.

Read more
7 Mar 2024 07:21

GSK reports more encouraging trial results for Blenrep

(Sharecast News) - GSK unveiled encouraging results from its 'DREAMM-8' phase three trial on Thursday, comparing the efficacy of 'Blenrep', or belantamab mafodotin, in combination with pomalidomide plus dexamethasone, or PomDex, against the standard treatment of bortezomib plus PomDex in relapsed or refractory multiple myeloma patients.

Read more
5 Mar 2024 11:03

GSK says ViiV's cabotegravir study supports longer HIV dose interval

(Alliance News) - GSK PLC on Tuesday celebrated study results from ViiV Healthcare Ltd, that showed an investigational formulation of cabotegravir can be dosed at four-month intervals.

Read more
5 Mar 2024 07:26

GSK's ViiV upbeat on ultra-long-acting HIV treatment study

(Sharecast News) - GSK announced on Tuesday that its specialist GIV joint venture with Pfizer and Shionogi, ViiV Healthcare, had reported encouraging results from its phase one clinical trial of an investigational formulation of cabotegravir, termed cabotegravir ultra long-acting (CAB-ULA).

Read more
29 Feb 2024 09:44

TOP NEWS: GSK avoids "protracted litigation" with Zantac settlement

(Alliance News) - GSK PLC on Thursday emphasised its commitment to science, as it reached another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
29 Feb 2024 07:22

GSK reaches settlement in another Zantac case

(Sharecast News) - GSK announced a confidential settlement with Boyd/Steenvoord, effectively resolving a case filed in California state court over its discontinued heartburn drug Zantac.

Read more
26 Feb 2024 08:25

GSK gonorrhoea treatment achieves efficacy endpoint in latest trial

(Alliance News) - GSK PLC on Monday announced positive results from the latest trial of its oral gonorrhoea treatment, showing it to be on par with intramuscular therapies.

Read more
26 Feb 2024 07:22

GSK reports positive results from gonorrhoea treatment trial

(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.

Read more
21 Feb 2024 09:47

GSK reports encouraging results for ViiV's Cabenuva HIV treatment

(Alliance News) - GSK PLC on Wednesday said that its majority-owned company ViiV Healthcare had received positive interim data from ongoing trials of its injectable HIV treatment.

Read more
21 Feb 2024 07:22

GSK's ViiV sees success in latest HIV treatment trial

(Sharecast News) - GSK's specialist HIV unit ViiV Healthcare, which it owns in partnership with Pfizer and Shionogi, unveiled promising findings from the 'LATITUDE' phase three trial of its long-acting injectable HIV treatment Cabenuva on Wednesday.

Read more
20 Feb 2024 15:10

PRESS: AJ Bell founder to join Applied Nutrition ahead of IPO - Sky

(Alliance News) - Supplements maker Applied Nutrition, plotting a London stock market float, is to add AJ Bell PLC founder Andy Bell as its chair, Sky News reported on Tuesday.

Read more
20 Feb 2024 08:55

IN BRIEF: Diageo welcomes GSK's CFO as non-executive director

Diageo PLC - London-based brewer and distiller sells more than 200 drinks brands, including Guinness stout, Captain Morgan rum and Johnnie Walker whisky - Appoints GSK PLC's chief financial officer and executive director, Julie Brown, as a non-executive director. Says she will succeed Alan Stewart as chair of the audit committee after his retirement following the firm's annual general meeting in September. Chair Javier Ferran says: "Julie brings many years of experience in financial, commercial and strategic roles in international companies operating in highly regulated industries. She is strongly committed to enabling diversity in business and to creating sustainable, long-term value for stakeholders. I look forward to her contribution to Board discussions and to working with her in progressing Diageo's ambition to be one of the most trusted and respected consumer products companies in the world."

Read more
15 Feb 2024 14:44

UK dividends calendar - next 7 days

Friday 16 February 
JPMorgan Asia Growth & Income PLCdividend payment date
JPMorgan Japan Small Cap Growth & Income PLCdividend payment date
Murray International Trust PLCdividend payment date
Premier Miton Group PLCdividend payment date
Schroder Oriental Income Funddividend payment date
Solid State PLCdividend payment date
Monday 19 February 
no events scheduled 
Tuesday 20 February 
Invesco Bond Income Plus Ltd 
Wednesday 21 February 
no events scheduled 
Thursday 22 February 
abrdn Asia Focus PLCex-dividend payment date
Alumasc Group PLCex-dividend payment date
AstraZeneca PLCex-dividend payment date
BlackRock Throgmorton Trust PLCex-dividend payment date
Braemar PLCex-dividend payment date
easyJet PLCex-dividend payment date
Ecofin US Renewables Infrastructure Trust PLCex-dividend payment date
Endeavour Mining PLCex-dividend payment date
FRP Advisory Group PLCex-dividend payment date
Gateley Holdings PLCex-dividend payment date
GSK PLCex-dividend payment date
Hercules Site Services PLCex-dividend payment date
Jersey Electricity PLCex-dividend payment date
Land Securities Group PLCex-dividend payment date
Molten Ventures VCT PLCex-dividend payment date
Northern Bear PLCex-dividend payment date
Redrow PLCex-dividend payment date
Samuel Heath & Sons PLCex-dividend payment date
Titon Holdings PLCex-dividend payment date
Unilever PLCex-dividend payment date
Van Elle Holdings PLCex-dividend payment date
Virgin Money UK PLCex-dividend payment date
Witan Investment Trust PLCex-dividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
15 Feb 2024 11:02

Berenberg hikes target price on GSK

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker GSK from £16.50 to £18.20 on Thursday, stating the group was moving closer to offsetting losses associated with the expiry of its patent on HIV drug dolutegravir.

Read more
15 Feb 2024 09:45

LONDON BROKER RATINGS: Jefferies cuts Kingfisher but Citi raises

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.